Invesco Ltd.

Position in FTRE — Fortrea Holdings Inc.

CIK 914208 Atlanta, GA

Position in FTRE

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$6,778,366

-$6,928,741 QoQ

Shares Held

719,572

-9.4% QoQ

Ownership

0.761%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 96.3075272523111.ToString("F0")% None 3.692472747688904.ToString("F0")%

Healthcare · as of Mar 31, 2026

Invesco Ltd. holds $8,191,566,293 across 258 Biotechnology names. FTRE ranks #62 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,724,478	$1,332,400,669
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,561,057	$1,143,614,384
3	ARGX	Argenx SE	594,697	$434,277,482
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,291,726	$427,393,371
5	INCY	Incyte Corp	3,870,764	$364,316,298
6	BBIO	BridgeBio Pharma, Inc.	4,592,814	$341,062,362
7	INSM	INSMED Inc	1,988,968	$325,236,040
8	HALO	Halozyme Therapeutics, Inc.	4,012,494	$259,327,483

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,778,366	719,572	-9.4%	Shares	Defined	2026-05-12
2025-12-31	$13,707,107	794,615	+9.0%	Shares	Defined	2026-02-19
2025-09-30	$6,136,730	728,828	-18.8%	Shares	Defined	2025-11-13
2025-06-30	$4,434,911	897,756	+26.5%	Shares	Defined	2025-08-13
2025-03-31	$5,356,706	709,498	+29.9%	Shares	Defined	2025-05-12
2024-12-31	$10,185,882	546,160	+20.5%	Shares	Defined	2025-02-13
2024-09-30	$9,067,720	453,386	-33.5%	Shares	Defined	2024-11-12
2024-06-30	$15,907,001	681,534	+66.3%	Shares	Defined	2024-08-13
2024-03-31	$16,455,029	409,941	-25.3%	Shares	Defined	2024-05-14
2023-12-31	$19,161,040	549,027	+0.4%	Shares	Defined	2024-02-13
2023-09-30	$15,631,777	546,757	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.